Patient Capital Management’s Mattel MAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,794,343
Closed -$55.4M 42
2025
Q4
$55.4M Buy
2,794,343
+695,081
+33% +$13.4M 2.14% 22
2025
Q3
$35.3M Buy
2,099,262
+634,864
+43% +$11.6M 1.41% 29
2025
Q2
$28.9M Sell
1,464,398
-847,256
-37% -$15.1M 1.3% 29
2025
Q1
$44.9M Sell
2,311,654
-220,818
-9% -$4.38M 2.31% 21
2024
Q4
$44.9M Sell
2,532,472
-4,173
-0.2% -$78.9K 2.07% 27
2024
Q3
$48.3M Sell
2,536,645
-29,426
-1% -$542K 2.37% 22
2024
Q2
$41.7M Sell
2,566,071
-600,713
-19% -$10.9M 2.22% 23
2024
Q1
$62.7M Sell
3,166,784
-122,287
-4% -$2.32M 3.05% 12
2023
Q4
$62.1M Sell
3,289,071
-233,767
-7% -$4.55M 3.29% 12
2023
Q3
$77.6M Sell
3,522,838
-126,350
-3% -$2.7M 4.55% 6
2023
Q2
$71.3M Buy
3,649,188
+3,205,688
+723% +$57.9M 3.97% 7
2023
Q1
$8.16M Buy
443,500
+18,000
+4% +$334K 3.64% 8
2022
Q4
$7.59M Sell
425,500
-7,800
-2% -$141K 3.69% 7
2022
Q3
$8.21M Sell
433,300
-33,700
-7% -$754K 4.1% 7
2022
Q2
$10.4M Buy
467,000
+40,000
+9% +$945K 4.62% 4
2022
Q1
$9.48M Buy
427,000
+23,300
+6% +$533K 3.21% 11
2021
Q4
$8.7M Buy
+403,700
New +$8.47M 2.51% 13

Other funds holding MAT

Patient Capital Management's MAT Position: Q1 2026 in Review

Patient Capital Management sold out of Mattel (MAT) in Q1 2026, closing a stake of 2,794,343 shares — an estimated $55.4M sold.

Patient Capital Management first reported a position in MAT in Q4 2021 and held it in 17 quarters. The position peaked at $77.6M in Q3 2023. 428 funds tracked by Wall St. Rank hold MAT as of Q1 2026.

  • Patient Capital Management reported no remaining Mattel position as of Q1 2026 after selling out during the quarter.
  • Patient Capital Management sold 2,794,343 Mattel shares in Q1 2026, an estimated $55.4M.
  • Patient Capital Management first reported a position in Mattel in Q4 2021 and held it in 17 quarters.
  • Patient Capital Management's Mattel position peaked at $77.6M in Q3 2023.
  • 428 funds tracked by Wall St. Rank held Mattel as of Q1 2026.

Based on Patient Capital Management's 13F filing for Q1 2026, filed 14 May 2026.